These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 10870853

  • 1. Impact of a 4-week treatment with prostaglandin E1 on health-related quality of life of patients with intermittent claudication.
    Mangiafico RA, Messina R, Attinà T, Dell'Arte S, Giuliano L, Malatino LS.
    Angiology; 2000 Jun; 51(6):441-9. PubMed ID: 10870853
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial.
    Ahimastos AA, Walker PJ, Askew C, Leicht A, Pappas E, Blombery P, Reid CM, Golledge J, Kingwell BA.
    JAMA; 2013 Feb 06; 309(5):453-60. PubMed ID: 23385271
    [Abstract] [Full Text] [Related]

  • 10. A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial.
    Beebe HG, Dawson DL, Cutler BS, Herd JA, Strandness DE, Bortey EB, Forbes WP.
    Arch Intern Med; 1999 Sep 27; 159(17):2041-50. PubMed ID: 10510990
    [Abstract] [Full Text] [Related]

  • 11. Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease.
    Money SR, Herd JA, Isaacsohn JL, Davidson M, Cutler B, Heckman J, Forbes WP.
    J Vasc Surg; 1998 Feb 27; 27(2):267-74; discussion 274-5. PubMed ID: 9510281
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of severe intermittent claudication: ORACLE-PGE1 short term study. A randomised 40-week study. Evaluation of efficacy and costs].
    Cesarone MR, Belcaro G, Nicolaides AN, Griffin M, Geroulakos G, Ramaswami G, Cazaubon M, Barsotti A, Vasdekis S, Christopoulos D, Agus G, Bavera P, Mondani P, Ippolito E, Flenda F.
    Minerva Cardioangiol; 2002 Dec 27; 50(6):683-90. PubMed ID: 12473989
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of arm-ergometry versus treadmill exercise training to improve walking distance in patients with claudication.
    Treat-Jacobson D, Bronas UG, Leon AS.
    Vasc Med; 2009 Aug 27; 14(3):203-13. PubMed ID: 19651669
    [Abstract] [Full Text] [Related]

  • 14. Randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of AS-013, a prostaglandin E1 prodrug, in patients with intermittent claudication.
    Belch JJ, Bell PR, Creissen D, Dormandy JA, Kester RC, McCollum RD, Mizushima Y, Ruckley CV, Scurr JH, Wolfe JH.
    Circulation; 1997 May 06; 95(9):2298-302. PubMed ID: 9142008
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of cloricromene on intermittent claudication. A randomized, double-blind, placebo-controlled trial in patients treated with aspirin: effect on claudication distance and quality of life. CRAMPS Investigator Group. Cloricromene Randomized Arteriopathy Multicenter Prospective Study.
    Gresele P, Migliacci R, Di Sante G, Nenci GG, CRAMPS Investigator Group.
    Vasc Med; 2000 May 06; 5(2):83-9. PubMed ID: 10943584
    [Abstract] [Full Text] [Related]

  • 17. A feasibility double-blind randomized placebo-controlled trial of extracorporeal shockwave therapy as a novel treatment for intermittent claudication.
    Harwood AE, Green J, Cayton T, Raza A, Wallace T, Carradice D, Chetter IC, Smith GE.
    J Vasc Surg; 2018 Feb 06; 67(2):514-521.e2. PubMed ID: 28943002
    [Abstract] [Full Text] [Related]

  • 18. Improvement of peripheral and cardiopulmonary performance after a short-term exercise program with additive prostaglandin E1.
    Cachovan M, Rogatti W.
    Angiology; 2001 Jun 06; 52(6):381-91. PubMed ID: 11437028
    [Abstract] [Full Text] [Related]

  • 19. [Rehabilitation program in patients with moderate-to-severe intermittent claudication: immediate results and one year follow-up].
    Rossini D, Bulckaen M, Di Marco S, Giovannetti R, Giuntoli F, Lacopetti L, Vergoni W.
    Monaldi Arch Chest Dis; 2007 Jun 06; 68(2):110-4. PubMed ID: 17886772
    [Abstract] [Full Text] [Related]

  • 20. Effects of regular physical training in a supervised class and additional intravenous prostaglandin E1 and naftidrofuryl infusion therapy in patients with intermittent claudication--a controlled study.
    Diehm C, Kühn A, Strauss R, Hübsch-Müller C, Kübler W.
    Vasa Suppl; 1989 Jun 06; 28():26-30. PubMed ID: 2609241
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.